Key Insights

Highlights

Treatment Research

1 treatments under study, led by Virusspecific Cytotoxic T Lymphocytes Vctls

Related Conditions

Often studied with 18 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07873970Early Phase 1Not Yet Recruiting

25BT056: Basket Study of Viral Cytotoxic T Lymphocytes

Showing all 1 trials

Research Network

Common Treatments

  • Virusspecific Cytotoxic T Lymphocytes Vctls1

Active Sponsors

  • Children's Hospital of Philadelphia1

Top Investigators

Related Conditions

  • Severe Combined Immunodeficiency Scid1
  • Acquired Immunodeficiency1
  • Refractory Viral Infection1
  • Adenovirus Infection1
  • Epsteinbarr Virus Infection Reactivation1

Activity Timeline